BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 16972956)

  • 1. Successful treatment of confluent and reticulated papillomatosis with a combination of doxycycline and topical tretinoin.
    Ting IPL; Kiing JW
    J R Coll Physicians Edinb; 2024 Mar; 54(1):59-61. PubMed ID: 38357752
    [No Abstract]   [Full Text] [Related]  

  • 2. Concomitant confluent and reticulated papillomatosis and acanthosis nigricans in patients with skin of color and need for early interventions for insulin resistance.
    Enwereji N; Mallett J
    Int J Womens Dermatol; 2023 Dec; 9(4):e119. PubMed ID: 37927368
    [No Abstract]   [Full Text] [Related]  

  • 3. Appearances may be deceptive: florid cutaneous and mucosal papillomatosis.
    Hung YT; Wang FY
    Clin Med (Lond); 2023 Jan; 23(1):97-98. PubMed ID: 36697013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confluent and reticulated papillomatosis : a review of the literature.
    Scheinfeld N
    Am J Clin Dermatol; 2006; 7(5):305-13. PubMed ID: 17007541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic Ovarian Syndrome-associated Confluent and Reticulated Papillomatosis: Report of a Patient Successfully Treated with Azithromycin.
    Fite LP; Cohen PR
    J Clin Aesthet Dermatol; 2017 Sep; 10(9):30-35. PubMed ID: 29344325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confluent and reticulated papillomatosis: diagnostic and treatment challenges.
    Lim JH; Tey HL; Chong WS
    Clin Cosmet Investig Dermatol; 2016; 9():217-23. PubMed ID: 27601929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant confluent and reticulated papillomatosis and acanthosis nigricans in an obese girl with insulin resistance successfully treated with oral minocycline: Case report and published work review.
    Fukumoto T; Kozaru T; Sakaguchi M; Oka M
    J Dermatol; 2017 Aug; 44(8):954-958. PubMed ID: 28295566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six cases of confluent and reticulated papillomatosis alleviated by various antibiotics.
    Jang HS; Oh CK; Cha JH; Cho SH; Kwon KS
    J Am Acad Dermatol; 2001 Apr; 44(4):652-5. PubMed ID: 11260541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is confluent and reticulated papillomatosis without papillomatosis early or late stage of confluent and reticulated papillomatosis?
    Atasoy M; Aliağaoğlu C
    J Cutan Pathol; 2006 Sep; 33 Suppl 2():52-4. PubMed ID: 16972956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of early onset confluent and reticulated papillomatosis with an unusual localization.
    Atasoy M; Aliağaoğlu C; Erdem T
    J Dermatol; 2006 Apr; 33(4):273-7. PubMed ID: 16674793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confluent and reticulated papillomatosis without papillomatosis.
    Mutasim DF
    J Am Acad Dermatol; 2003 Dec; 49(6):1182-4. PubMed ID: 14639415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Confluent and reticulated papillomatosis Gougerot-Carteaud successfully treated with minocycline].
    Löwenstein M; Metzler G; Röcken M; Schaller M
    J Dtsch Dermatol Ges; 2006 Jul; 4(7):556-8. PubMed ID: 16827913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confluent and reticulated papillomatosis (Gougerot-Carteaud syndrome) in two brothers.
    Açıkgöz G; Hüseynov S; Ozmen I; Oztürk Meral A; Gamsızkan M; Calışkan E
    Acta Dermatovenerol Croat; 2014; 22(1):57-9. PubMed ID: 24813844
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.